Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparative Effectiveness of Alternative Intervals between First and Second Doses of the mRNA COVID-19 Vaccines: a Trial Emulation Approach

View ORCID ProfileKayoko Shioda, Alexander Breskin, Pravara Harati, Allison Chamberlain, Benjamin A Lopman, Elizabeth T. Rogawski McQuade
doi: https://doi.org/10.1101/2023.03.06.23286848
Kayoko Shioda
1Gangarosa Department of Environmental Health and Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
PhD, DVM, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kayoko Shioda
  • For correspondence: kayoko.shioda@aya.yale.edu
Alexander Breskin
2Regeneron Pharmaceuticals, Tarrytown, NY, USA; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
PhD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pravara Harati
3Georgia Department of Public Health, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison Chamberlain
4Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
PhD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin A Lopman
4Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth T. Rogawski McQuade
4Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
PhD, MSPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

Individual-level data on COVID-19 test results from the Georgia State Electronic Notifiable Disease Surveillance System (SendSS) and COVID-19 vaccination from the Georgia Department of Public Health (GDPH) are also not publicly available, but aggregated data are available on the GDPH COVID-19 website.

Back to top
PreviousNext
Posted March 08, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparative Effectiveness of Alternative Intervals between First and Second Doses of the mRNA COVID-19 Vaccines: a Trial Emulation Approach
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparative Effectiveness of Alternative Intervals between First and Second Doses of the mRNA COVID-19 Vaccines: a Trial Emulation Approach
Kayoko Shioda, Alexander Breskin, Pravara Harati, Allison Chamberlain, Benjamin A Lopman, Elizabeth T. Rogawski McQuade
medRxiv 2023.03.06.23286848; doi: https://doi.org/10.1101/2023.03.06.23286848
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Comparative Effectiveness of Alternative Intervals between First and Second Doses of the mRNA COVID-19 Vaccines: a Trial Emulation Approach
Kayoko Shioda, Alexander Breskin, Pravara Harati, Allison Chamberlain, Benjamin A Lopman, Elizabeth T. Rogawski McQuade
medRxiv 2023.03.06.23286848; doi: https://doi.org/10.1101/2023.03.06.23286848

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (577)
  • Anesthesia (139)
  • Cardiovascular Medicine (1942)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (331)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (697)
  • Epidemiology (11092)
  • Forensic Medicine (8)
  • Gastroenterology (621)
  • Genetic and Genomic Medicine (3162)
  • Geriatric Medicine (307)
  • Health Economics (561)
  • Health Informatics (2040)
  • Health Policy (862)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12704)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2980)
  • Nursing (163)
  • Nutrition (462)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1548)
  • Ophthalmology (476)
  • Orthopedics (185)
  • Otolaryngology (265)
  • Pain Medicine (201)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (910)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (354)
  • Psychiatry and Clinical Psychology (2779)
  • Public and Global Health (5587)
  • Radiology and Imaging (1090)
  • Rehabilitation Medicine and Physical Therapy (631)
  • Respiratory Medicine (757)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (288)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (131)